NM_000745.4:c.*1843T>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000745.4(CHRNA5):c.*1843T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.033 in 158,372 control chromosomes in the GnomAD database, including 125 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.032   (  111   hom.,  cov: 32) 
 Exomes 𝑓:  0.058   (  14   hom.  ) 
Consequence
 CHRNA5
NM_000745.4 3_prime_UTR
NM_000745.4 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.504  
Publications
8 publications found 
Genes affected
 CHRNA5  (HGNC:1959):  (cholinergic receptor nicotinic alpha 5 subunit) The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010] 
 CHRNA3  (HGNC:1957):  (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009] 
CHRNA3 Gene-Disease associations (from GenCC):
- urinary bladder, atony ofInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0556  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0320  AC: 4865AN: 152142Hom.:  111  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
4865
AN: 
152142
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0578  AC: 353AN: 6112Hom.:  14  Cov.: 4 AF XY:  0.0602  AC XY: 180AN XY: 2988 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
353
AN: 
6112
Hom.: 
Cov.: 
4
 AF XY: 
AC XY: 
180
AN XY: 
2988
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
94
American (AMR) 
 AF: 
AC: 
0
AN: 
2
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
44
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
14
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
134
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
4
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
10
European-Non Finnish (NFE) 
 AF: 
AC: 
340
AN: 
5582
Other (OTH) 
 AF: 
AC: 
10
AN: 
228
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.493 
Heterozygous variant carriers
 0 
 15 
 31 
 46 
 62 
 77 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0320  AC: 4866AN: 152260Hom.:  111  Cov.: 32 AF XY:  0.0305  AC XY: 2272AN XY: 74434 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
4866
AN: 
152260
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2272
AN XY: 
74434
show subpopulations 
African (AFR) 
 AF: 
AC: 
506
AN: 
41548
American (AMR) 
 AF: 
AC: 
367
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
72
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
45
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
95
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
277
AN: 
10606
Middle Eastern (MID) 
 AF: 
AC: 
6
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
3427
AN: 
68030
Other (OTH) 
 AF: 
AC: 
62
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 242 
 484 
 725 
 967 
 1209 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 60 
 120 
 180 
 240 
 300 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
58
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.